Citation Impact
Citing Papers
Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report
2016 Standout
Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report
2012 Standout
Challenges in the Treatment of Chronic Wounds
2015 Standout
Graft microvascular disease in solid organ transplantation
2014 StandoutNobel
“Rescue” regimens after Helicobacter pylori treatment failure
2008
Intravenous hMSCs Improve Myocardial Infarction in Mice because Cells Embolized in Lung Are Activated to Secrete the Anti-inflammatory Protein TSG-6
2009
Calcineurin Inhibitor Nephrotoxicity
2009 Standout
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
2016 Standout
Ulcerative Colitis
2011 Standout
Review article: 13C‐urea breath test in the diagnosis of Helicobacter pylori infection – a critical review
2004
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
European evidence based consensus for endoscopy in inflammatory bowel disease
2013 Standout
Alternative and rescue treatment regimens for Helicobacter pylori eradication
2002
Invasive and non‐invasive tests for Helicobacter pylori infection
2000
Third-Line Rescue Therapy with Bismuth-Containing Quadruple Regimen After Failure of Two Treatments (with Clarithromycin and Levofloxacin) for H. pylori Infection
2013
Edible ginger-derived nanoparticles: A novel therapeutic approach for the prevention and treatment of inflammatory bowel disease and colitis-associated cancer
2016 Standout
Local induction of angiotensin-converting enzyme in the kidney as a mechanism of progressive renal diseases
2003
The effectiveness of rifabutin triple therapy for patients with difficult‐to‐eradicate Helicobacter pylori in clinical practice
2007
Helicobacter Pylori “Test-and-Treat” Strategy for Management of Dyspepsia: A Comprehensive Review
2013
A 10‐day levofloxacin‐based triple therapy in patients who have failed two eradication courses
2005
The Intrarenal Renin-Angiotensin System: From Physiology to the Pathobiology of Hypertension and Kidney Disease
2007
Mitochondrial transfer from bone-marrow–derived stromal cells to pulmonary alveoli protects against acute lung injury
2012 Standout
TFOS DEWS II pathophysiology report
2017 Standout
Helicobacter pylori ‘rescue’ regimen when proton pump inhibitor‐based triple therapies fail
2002
Cellular and molecular mechanisms of renal fibrosis
2011 Standout
Effector Mechanisms of Rejection
2013
Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders
2017
Pouchitis: What Every Gastroenterologist Needs to Know
2013
Treatment options for patients with Helicobacter pylori infection resistant to one or more eradication attempts
2003
Omeprazole triple therapy versus omeprazole quadruple therapy for healing duodenal ulcer and eradication of Helicobacter pylori infection
2002
STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD
2021 Standout
Crohn's disease
2016 Standout
Results of the 2nd part Scientific Workshop of the ECCO (II): Measures and markers of prediction to achieve, detect, and monitor intestinal healing in Inflammatory Bowel Disease
2011
Role of antibiotic sensitivity testing before first‐line Helicobacter pylori eradication treatments
2003
Evolving paradigms for repair of tissues by adult stem/progenitor cells (MSCs)
2010
Evaluation of three different tests for the detection of stool antigens to diagnose Helicobacter pylori infection in patients with upper gastrointestinal bleeding
2004
Systematic review and meta‐analysis: levofloxacin‐based rescue regimens after Helicobacter pylori treatment failure
2005
The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine
2013 Standout
Rabeprazole: the role of proton pump inhibitors inHelicobacter pylorieradication
2005
Ulcerative colitis
2016 Standout
TFOS DEWS II Management and Therapy Report
2017 Standout
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 3: Special situations
2012
Renal injury due to renin–angiotensin–aldosterone system activation of the transforming growth factor-β pathway
2006
Adverse events with bismuth salts for Helicobacter pylori eradication: Systematic review and meta-analysis
2008
Blood, urine, stool, breath, money, and Helicobacter pylori
2001
H pylori antibiotic resistance: prevalence, importance, and advances in testing
2004 Standout
Physiology of Local Renin-Angiotensin Systems
2006 Standout
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 1: Definitions and diagnosis
2012
Helicobacter pyloriInfection
2002 Standout
Mesenchymal stem cells transplantation ameliorates glomerular injury in streptozotocin-induced diabetic nephropathy in rats via inhibiting oxidative stress
2014
Photodynamic therapy: a new antimicrobial approach to infectious disease?
2004 Standout
Ulcerative colitis
2020 Standout
树鼩——作为一种新颖的非人灵长类实验疾病动物模型
2017 Standout
High efficacy of 1‐week doxycycline‐ and amoxicillin‐based quadruple regimen in a culture‐guided, third‐line treatment approach for Helicobacter pylori infection
2004
Angiotensin II activates the Smad pathway during epithelial mesenchymal transdifferentiation
2008
Scar wars: mapping the fate of epithelial–mesenchymal–myofibroblast transition
2011
New Insights into Epithelial-Mesenchymal Transition in Kidney Fibrosis
2009
Pooled Analysis on the Efficacy of the Second-line Treatment Regimens for Helicobacter pylori Infection
2001
Empirical rescue therapy after Helicobacter pylori treatment failure: a 10‐year single‐centre study of 500 patients
2007
Helicobacter pylori first‐line treatment and rescue options in patients allergic to penicillin
2005
Mesenchymal stem cells: A revolution in therapeutic strategies of age-related diseases
2012
Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report
2006 Standout
A global consensus on the classification, diagnosis and multidisciplinary treatment of perianal fistulising Crohn's disease
2014
Systematic review: monotherapy with antitumour necrosis factor α agents versus combination therapy with an immunosuppressive for IBD
2014
International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding
2010 Standout
SGLT2 inhibitor empagliflozin reduces renal growth and albuminuria in proportion to hyperglycemia and prevents glomerular hyperfiltration in diabetic Akita mice
2013
Methotrexate for maintenance of remission in ulcerative colitis
2015
Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis
2015 StandoutNobel
Bone‐marrow mesenchymal stem cell transplantation to treat diabetic nephropathy in tree shrews
2014
Interventions for enhancing medication adherence
2008 Standout
Systematic review with meta‐analysis: mucosal healing is associated with improved long‐term outcomes in Crohn's disease
2015
Helicobacter pylori eradication: proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics for 1 week—a meta‐analysis of efficacy
2000
European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis
2008
Pathogenesis ofHelicobacter pyloriInfection
2006 Standout
Interventions for enhancing medication adherence
2014 Standout
Mechanisms of Renal Fibrosis
2017 Standout
Works of Daniel Carpio being referenced
Evaluation of adalimumab therapy in multidisciplinary strategy for perianal Crohn's disease patients with infliximab failure
2010
Clinical, biological, and endoscopic responses to adalimumab in antitumor necrosis factor-naive Crohn’s disease
2015
Renal angiotensin II up-regulation and myofibroblast activation in human membranous nephropathy
2003
Methotrexate in ulcerative colitis: A Spanish multicentric study on clinical use and efficacy
2011
7‐day rescue therapy with ranitidine bismuth citrate after Helicobacter pylori treatment failure
2005
One-week therapy with pantoprazole versus ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication
2000
Gremlin: A Novel Mediator of Epithelial Mesenchymal Transition and Fibrosis in Chronic Allograft Nephropathy
2008
Endovenous Administration of Bone Marrow-Derived Multipotent Mesenchymal Stromal Cells Prevents Renal Failure in Diabetic Mice
2009
Systemic Administration of Multipotent Mesenchymal Stromal Cells Reverts Hyperglycemia and Prevents Nephropathy in Type 1 Diabetic Mice
2008
Altered expression and localization of insulin receptor in proximal tubule cells from human and rat diabetic kidney
2012
13C-urea breath test for the diagnosis of Helicobacter pylori infection before treatment: is citric acid necessary?
2000
Helicobacter pylori “test-and-scope” strategy for dyspeptic patients. Is it useful and safe?
2001
Ulcerative colitis in northern Portugal and Galicia in Spain
2009
Seven‐day ‘rescue’ therapy after Helicobacter pylori treatment failure: omeprazole, bismuth, tetracycline and metronidazole vs. ranitidine bismuth citrate, tetracycline and metronidazole
1999
Efficacy of infliximab rescue therapy in patients with chronic refractory pouchitis: A multicenter study
2011